Revision 2 for 'Osteofibrous dysplasia'

All Revisions - View changeset

Osteofibrous Dysplasia

Osteofibrous dysplasia is a benign fibro-osseous cortical lesion. It is most commonly seen in the mid-diaphysis of the tibia.


  • Most are seen below the age of 5 years.
  • Male children are more commonly affected than female children.
  • Tibia is the most common bone. It can be seen in other long bones, such as fibula, radius, and ulna.
  • It can be locally destructive and may result in pathologic fracture.
  • They usually stabilize or spontaneously regress once the child is older than 10 years old.
  • High rates of local recurrence is noted after surgery with some aggressive recurrence, possibly due to components of adamantinoma or possible transformation to adamantinoma.



Clinical Presentation

  • Most present with pain and swelling. 
  • May present secondary to pathologic fracture.


  • It is benign condition, seen as trabecular bone woven within fibrous stroma. 
  • It is considered as part of spectrum of adamantinomas and osteofibrous dysplasia-like adamantinoma.

Imaging features: General

  • Usually smaller than adamantinomas (mean 6-7 cm compared to 10-17 cm for adamantinoma).
  • Osteofibrous dysplasia is usually seen in pediatric age group (adamantinoma are usually seen in adults).

Plain radiograph

Plain radiograph remains the initial and chief investigation.

  • Location along the long axis: mid diaphysis
  • Location along the transverse axis: cortical
  • Desnity: lucent or ground-glass
  • Zone of transition: narrow
  • Margins: well-defined and sclerotic
  • Other features which may be present: Pseudotrabeculations, anterior bowing
  • Negative features: no periosteal reaction, no nidus


MRI is the next step in investigating suspected fubrosseusys dysplasia

  • Has homogeneous hyperintensity on T2-weighted images.
  • Can extend into the medullary cavity, but a large medullary component should raise suspicion for adamantinoma, which often have complete medullary canal involvement.
  • No soft-tissue component.
  • No cortical destruction.


Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.